Skip to main content

Prototype Prescribing Outlier Dashboard for NHS Bury CCG

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all CCGs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given CCG is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all CCG's chemical:subparagraph ratios is provided, with this CCG's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where NHS Bury CCG is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Tocilizumab 1 Rheumatic disease suppressant drugs 6,112 0.00 0.00 0.00 10.20
Fusidic acid 4 Some other antibacterials 270 0.01 0.00 0.00 7.88
Erythromycin stearate 90 Macrolides 6,193 0.01 0.00 0.00 6.83
Proguanil hydrochloride with atovaquone 4 Antimalarials 1,981 0.00 0.00 0.00 6.57
Mometasone furoate/olopatadine hydrochloride 2 Drugs used in nasal allergy 13,644 0.00 0.00 0.00 6.39
Hepatitis B 313 Vaccines and antisera 29,275 0.01 0.00 0.00 5.18
Wool fat 1 Vehicles 1 1.00 0.06 0.19 5.05
Fondaparinux sodium 27 Parenteral anticoagulants 347 0.08 0.01 0.01 5.04
Co-danthrusate (Dantron/docusate sodium) 7 Stimulant laxatives 12,912 0.00 0.00 0.00 4.85
Fidaxomicin 4 Some other antibacterials 270 0.01 0.00 0.00 4.58

Prescribing where NHS Bury CCG is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Cetomacrogol 0 Vehicles 1 0.00 0.89 0.23 -3.89
    Folic acid 9,509 Drugs used in megaloblastic anaemias 24,542 0.39 0.67 0.12 -2.30
    Nicotine 148 Nicotine dependence 476 0.31 0.71 0.19 -2.10
    Gliclazide 8,701 Sulfonylureas 12,788 0.68 0.92 0.11 -2.09
    Ketoconazole 53 Antifungal preparations 3,428 0.02 0.04 0.01 -1.99
    Diclofenac sodium 64 Sunscreening preparations 692 0.09 0.38 0.15 -1.92
    Bisoprolol fumarate 48,675 Beta-adrenoceptor blocking drugs 85,397 0.57 0.64 0.04 -1.91
    Brinzolamide 934 Treatment of glaucoma 17,704 0.05 0.10 0.02 -1.90
    Cocois 99 Preparations for psoriasis 2,937 0.03 0.06 0.01 -1.90
    Methotrexate 2,590 Rheumatic disease suppressant drugs 6,112 0.42 0.59 0.09 -1.85